pharmaphorum July 5, 2022
Paul Tunnah

I recently had the pleasure of attending the PING Conference 2022, which had the tagline of ‘The Golden Age for Life Sciences Innovation’. In part, this was due to it being held at The Old Palace at Hatfield House, a location steeped in history and formerly the residence of Queen Elizabeth I, with whom ‘a golden age’ is often associated.

However, it also reflected the optimistic tone of the event, organised by VWV, which aimed to present some rays of light for the future as we (hopefully) emerge from the COVID pandemic.

Aspirations for the UK in life sciences

George Freeman, minister for science, research and innovation at the Department for Business, Energy and Industrial Strategy, opened proceedings by reminding...

Today's Sponsors

Oliver Wyman
Patient Bond
pCare

Today's Sponsors

Amwell
Oliver Wyman

Today's Sponsor

Patient Bond

 
Topics: Biotechnology, Health System / Hospital, Healthcare System, Pharma / Biotech, Provider, Public Health / COVID
Here are 4 key health policy items in the Inflation Reduction Act
Biotechs face brutal pipeline decisions as M&A continues to lag
House decision on drug price negotiations may have little impact on drug industry, some say
Inflation Reduction Act's Health Care Provisions Could Affect Employers
Moderna’s Omicron Booster Approved In The U.K. In World First